Bill Summary: The bill mandates that health insurers and the state Medicaid program provide coverage for biomarker testing when such testing is deemed medically necessary for the diagnosis, treatment, management, and ongoing monitoring of a patient's disease or condition. The bill specifies that biomarker tests should be covered based on established medical and scientific evidence, ensuring that patients receive timely and appropriate care tailored to their individual needs. 

How can YOU Help?

Contact your lawmakers and ask for support for New Hampshire SB 120! Personalized messages make a difference!